Spirulina maxima reduces inflammation and alveolar bone loss in Porphyromonas gingivalis-induced periodontitis

• Published in: Phytomedicine (Stuttgart) 2021-01, Vol.81, p.153420, Article 153420
• Main Authors: Kang, Min Song, Moon, Ji-Hoi, Park, Sang Cheol, Jang, Young Pyo, Choung, Se Young
• Format: Article
• Language: English
• Subjects: Alveolar Bone Loss - drug therapy; Alveolar Bone Loss - metabolism; Alveolar Bone Loss - microbiology; Alveolar bone loss recovery; Animals; Anti-inflammation; Anti-Inflammatory Agents, Non-Steroidal - chemistry; Anti-Inflammatory Agents, Non-Steroidal - pharmacology; Bacteroidaceae Infections - complications; Bacteroidaceae Infections - drug therapy; BMP-2/Smad pathway; Cytokines - genetics; Cytokines - metabolism; Gene Expression Regulation - drug effects; Male; Osteoblasts - drug effects; Osteoclasts - drug effects; Periodontitis; Periodontitis - drug therapy; Periodontitis - metabolism; Periodontitis - microbiology; Phycocyanin - analysis; Porphyromonas gingivalis; Rats; Rats, Sprague-Dawley; Smad Proteins - metabolism; Spirulina - chemistry; Spirulina maxima
• ISSN: 0944-7113; 1618-095X
• DOI: 10.1016/j.phymed.2020.153420

Periodontitis is a common oral disease characterized as inflammation on gingival tissue and alveolar bone resorption. Spirulina maxima has been reported to have anti-oxidative and anti-inflammatory effects on gastric ulcers. However, its effects on gingival inflammation and alveolar bone resorption of periodontitis have not been studied. This study was designed to investigate the effects of S. maxima on the P. gingivalis-induced periodontitis and to elucidate its mechanism. The phycocyanin contents in S. maxima were identified by high-performance liquid chromatography. 8-week old SD rats were induced periodontitis by inoculation with P. gingivalis for 14 days. The rats were then orally treated with S. maxima 100, 200, 400 mg/kg, or indomethacin (IND, positive control) 5 mg/kg for an additional 14 days. Inflammatory responses, expressions of collagenases in gingival tissue, osteoclast formation and activation, alveolar bone resorption, osteogenesis-related markers, and BMP2/Smad signaling in alveolar bone were measured. Pro-inflammatory cytokines such as TNF-α, IL-1β, IL-6, and inflammatory transcription factor NF-κB were decreased in gingival tissue by S. maxima administration. Also, myeloperoxidase (MPO) activity and matrix metalloproteinase (MMPs) expression were decreased by S. maxima administration. Conversely, S. maxima increased IL-4, anti-inflammatory cytokine from Th2 cells. The osteoprotegerin (OPG) / receptor activator of NF-κB ligand (RANKL) expression ratio, which represents osteoclast-osteoblast balance, was increased in S. maxima-treated groups. The alveolar bone loss and the number of TRAP-positive osteoclast cells were also declined in S. maxima-treated groups while the osteoblasts count was increased. Besides, in S. maxima-treated groups, the osteogenesis-related factors were promoted and BMP-2/Smad pathway was up-regulated in a periodontitis condition. S. maxima reduces periodontitis induced by P. gingivalis through anti-inflammatory effect and resultant reduction in bone loss, suggesting that S. maxima might be a potential agent for treating periodontitis. [Display omitted]